
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+10
Turnstone Biologics is a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy. Turnstones next-generation TIL therapy is based upon the identification, selection and expansion of the most potent tumor-reactive T cells, known as Selected TILs, and is designed to overcome the limitations of first-generation bulk TIL that have demonstrated objective responses only in limited tumor types. Turnstones most advanced program, TIDAL-01, is currently being evaluated in multiple Phase 1 studies in patients with colorectal cancer, breast cancer, head and neck cancer, uveal melanoma, and cutaneous...
Biotechnology,immuno-oncology,til therapy,cell therapy,cancer immunotherapy,immunotherapy,cancer,cancer research,cell therapy,viral immunotherapy,oncolytic virus,clinical trials,san diego,leadership,and opportunities
Turnstone biologics operates in the Biotechnology research industry.
Turnstone biologics's revenue is 11m - 100m
Turnstone biologics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.